| Cash and cash equivalents | 113.67M |
| Accounts receivable, net | 44.42M |
| Income tax receivable | 0 |
| Medical supplies | 10.34M |
| Deferred income tax assets | 8.68M |
| Prepaid expenses and other current assets | 12.26M |
| Current assets of discontinued operations | 45.5M |
| Total current assets | 234.86M |
| Property and equipment, net | 143.82M |
| Other assets | 22.42M |
| Non-current assets of discontinued operations | 3.08M |
| Total assets | 404.18M |
| Accounts payable | 17.09M |
| Income tax payable | 7.16M |
| Accrued compensation and benefits | 12.66M |
| Other accrued liabilities | 16.13M |
| Current portion of long-term debt and obligations under capital leases | 2.34M |
| Current liabilities of discontinued operations | 13.53M |
| Total current liabilities | 68.91M |
| Long-term debt | 0 |
| Obligations under capital leases | 4.3M |
| Other long-term obligations | 3.06M |
| Long-term liabilities of discontinued operations | 0 |
| Total liabilities | 76.26M |
| Commitments and contingencies (See Note 7) | 0 |
| Redeemable noncontrolling interest | 8.28M |
| Preferred stock, $0.01 par value, 10,000,000 shares authorized; none issued | 0 |
| Common stock, $0.01 par value, 50,000,000 shares authorized; 22,270,012 issued and 20,315,651 outstanding at June 30, 2011 22,423,666 issued and 20,469,305 outstanding at September 30, 2010 | 216K |
| Paid-in capital | 458.73M |
| Accumulated deficit | -103.92M |
| Accumulated other comprehensive loss | 0 |
| Treasury stock, at cost; 1,954,361 shares at June 30, 2011 and September 30, 2010 | -44.8M |
| Total MedCath Corporation stockholders' equity | 310.23M |
| Noncontrolling interest | 9.4M |
| Total equity | 319.63M |
| Total liabilities and equity | 404.18M |